Over $1 million was awarded this year to support multidisciplinary teams tackling key gaps in the areas of pediatric critical care and traumatic brain injury.

In a perspective piece published in NEJM AI, Weil Institute data science researchers comment on the shortcomings of existing methods for monitoring predictive AI models post-deployment in clinical settings.

A new traumatic brain injury blood test, introduced at Michigan Medicine in December 2024, is helping patients with head injuries avoid unnecessary CT scans and leave the hospital quicker.

Supported by the CancerX Accelerator Program, Fifth Eye will study the predictive capabilities of its AHI analytic in the setting of cytokine release syndrome—a common but potentially deadly side effect of cancer immunotherapies.

Investigators from the University of Michigan Max Harry Weil Institute for Critical Care Research and Innovation, in collaboration with the University of North Texas Health Science Center, have been awarded a highly competitive collaborative science grant from the American Heart Association (AHA) for $1 million to study the capabilities of a Weil Institute-developed wearable sensor in the early detection of critical heart conditions.

Hurley Medical Center is one of only a handful of sites across the country recognized as an official partner site of the SOCM program. Weil Institute member Dr. Florian Schmitzberger was recently named Medical Director of the SOCM course at Hurley and speaks more about this unique military-civilian partnership and the changing landscape of combat casualty care.